Abbott Laboratories ABT

101.29 0.22 0.22% as of 25 Sep
Market cap
$174.8B
P/E
32.8×
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month

Abbott Laboratories (ABT) Operating margin

Abbott Laboratories's operating margin over the twelve months to 30 June 2026 was 15.8%, down 2.4 percentage points from fiscal 2025 (18.2%). Over the past ten years it has ranged from 5.71% (fiscal 2017) to 19.6% (fiscal 2021); the current reading is higher than 82% of that period. That is above the Medical Devices industry median of −15.0% and above the Healthcare sector median of 0.00%.

Operating margin, annual

Annual

Period Operating margin Change (points)
FY2025 18.2% 1.90
FY2024 16.3% 0.12
FY2023 16.2% (3.01)
FY2022 19.2% (0.40)
FY2021 19.6% 4.08
FY2020 15.5% 1.27
FY2019 14.2% 2.27
FY2018 11.9% 6.23
FY2017 5.71% (8.80)
FY2016 14.5% 0.46

Quarterly

Period Operating margin Change (points)
Jun 2026 13.4% 1.39
Mar 2026 12.1% (7.59)
Dec 2025 19.6% 1.55
Sep 2025 18.1% (0.33)
42 more quarters

Against its own ten years

Low 5.71% High 19.6%
Ten-year median 15.5%
Current reading's percentile 82

Operating margin against peers

Company Operating margin
DXCM DexCom, Inc. compare 22.9%
EW Edwards Lifesciences Corporation compare 22.3%
SYK Stryker Corporation compare 21.4%
BSX Boston Scientific Corporation compare 19.8%
STE STERIS plc compare 18.9%
MDT Medtronic PLC compare 18.1%
ABT Abbott Laboratories 15.8%
GEHC GE HealthCare Technologies Inc. compare 12.9%
PHG Koninklijke Philips N.V. compare 9.64%
Medical Devices industry median −15.0%
Healthcare sector median 0.00%
Market median 0.00%

What Operating margin is

EBIT Margin tells an investor how much operating profit, before interest and taxes, a company keeps from each unit of revenue.

EBIT ÷ Revenue

The full definition of Operating margin →

More on ABT